SeraCare Life Sciences, Inc. is a manufacturer and provider of biological products and services for diagnostic, therapeutic, drug discovery and research organizations. It is a vendor-approved supplier to over 500 pharmaceutical and healthcare companies. Through strategic alliances with Biomat USA, Inc., the Company has access to a nationwide network of donor centers. Through its alliance with Proliant, Inc., the Company has access to bovine serum albumin, which has provided the basis for development of its bovine serum-based products. It also provides antibody-based products, which are used as active ingredients in therapeutic products (generally, drugs used to treat and manage diseases) and in diagnostic products (generally, diagnostic tests and test kits). In September 2004, the Company acquired BBI Diagnostics and BBI Biotechnology Research Laboratories divisions of Boston Biomedica, Inc. It also acquired substantially all of the assets of Genomics Collaborative, Inc. THIS IS A VALUE LOTTO PLAY! VALUATIONS = 50% UNDERVALUED! (WORTH $14 JUST BASED ON FUNDAMENTALS!) REUTERS COMPANY RESEARCH RATING: "OUTPERFORM" Shares Outstanding 13.5M Institutions Holding Shares 24 Held By Institutions (MRQ) 16.55% Percentage of Float 2.04%